BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32210616)

  • 1. LncRNA-SNHG16 Silencing Inhibits Prostate Carcinoma Cell Growth, Downregulate GLUT1 Expression and Reduce Glucose Uptake.
    Shao M; Yu Z; Zou J
    Cancer Manag Res; 2020; 12():1751-1757. PubMed ID: 32210616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA mortal obligate RNA transcript suppresses tumor cell proliferation in prostate carcinoma by inhibiting glucose uptake.
    Shi Z; Guo F; Jia D; Huang J; Chen J; Sun M; Qi F; Liang C
    Oncol Lett; 2019 Oct; 18(4):3787-3791. PubMed ID: 31516590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG16 promotes proliferation and migration in laryngeal squamous cell carcinoma via the miR-140-5p/NFAT5/Wnt/β-catenin pathway axis.
    Wan L; Gu D; Li P
    Pathol Res Pract; 2022 Jan; 229():153727. PubMed ID: 34911016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressing lncRNA
    Xu F; Zha G; Wu Y; Cai W; Ao J
    Onco Targets Ther; 2018; 11():8855-8863. PubMed ID: 30573973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC01638 lncRNA promotes cancer cell proliferation in hepatocellular carcinoma by increasing cancer cell glucose uptake.
    Chen X; Wang L; Wang H
    Oncol Lett; 2019 Oct; 18(4):3811-3816. PubMed ID: 31516592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ELF3-AS1 is involved in the regulation of oral squamous cell carcinoma cell proliferation by reprogramming glucose metabolism.
    Chu H; Li Z; Gan Z; Yang Z; Wu Z; Rong M
    Onco Targets Ther; 2019; 12():6857-6863. PubMed ID: 31686842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of lncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT-1.
    Bai J; Xu J; Zhao J; Zhang R
    Oncol Lett; 2019 Aug; 18(2):2007-2012. PubMed ID: 31423271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG16 functions as an oncogene by sponging miR-200a-3p in pancreatic cancer.
    Guo JQ; Yang ZJ; Wang S; Wu ZZ; Yin LL; Wang DC
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1718-1724. PubMed ID: 32141539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of the long non-coding RNA SNHG16 contributes to gastric cancer progression and metastasis.
    Lian D; Amin B; Du D; Yan W
    Cancer Biomark; 2017 Dec; 21(1):151-160. PubMed ID: 29081409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-‑coding RNA SNHG16 functions as a tumor activator by sponging miR‑373‑3p to regulate the TGF‑β‑R2/SMAD pathway in prostate cancer.
    Weng W; Liu C; Li G; Ruan Q; Li H; Lin N; Chen G
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA SNHG16 Exerts Oncogenic Functions in Promoting Proliferation of Glioma Through Suppressing p21.
    Zhou XY; Liu H; Ding ZB; Xi HP; Wang GW
    Pathol Oncol Res; 2020 Apr; 26(2):1021-1028. PubMed ID: 30972632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression.
    Chen H; Li M; Huang P
    J Cancer; 2019; 10(15):3571-3581. PubMed ID: 31293662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p.
    Xiao X; Jiang G; Zhang S; Hu S; Fan Y; Li G; Yu H; He S
    BMC Cancer; 2021 Apr; 21(1):355. PubMed ID: 33823834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 16 (SNHG16) Predicts Poor Prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.
    Guo Z; Zhang J; Fan L; Liu J; Yu H; Li X; Sun G
    Med Sci Monit; 2019 Mar; 25():2079-2086. PubMed ID: 30893293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA SNHG16 promotes the tumorigenicity of cervical cancer cells by recruiting transcriptional factor SPI1 to upregulate PARP9.
    Tao L; Wang X; Zhou Q
    Cell Biol Int; 2020 Mar; 44(3):773-784. PubMed ID: 31774223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG16 induced by TFAP2A modulates glycolysis and proliferation of endometrial carcinoma through miR-490-3p/HK2 axis.
    Zhang G; Ma A; Jin Y; Pan G; Wang C
    Am J Transl Res; 2019; 11(11):7137-7145. PubMed ID: 31814916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA SNHG16 Regulates the Growth of Human Lung Cancer Cells by Modulating the Expression of Aldehyde Dehydrogenase 2 (ALDH2).
    Li Y; Jiang L; Zhu Z; Fu B; Sun X; Jiao Y
    J Oncol; 2022; 2022():2411642. PubMed ID: 35646120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG16 drives proliferation, migration, and invasion of lung cancer cell through modulation of miR-520/VEGF axis.
    Chen L; Qiu CH; Chen Y; Wang Y; Zhao JJ; Zhang M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9522-9531. PubMed ID: 33015794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p.
    Yang X; Huang H; Wang X; Liu H; Liu H; Lin Z
    Cancer Cell Int; 2020; 20():38. PubMed ID: 32025219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
    Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
    J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.